Immunogenicity of a combined Diphtheria-Tetanus-Acellular Pertussis(DT-tricomponent Pa)-Hepatitis B (HB)-Inactivated Poliovirus (IPV) admixed with Haemophilus influenzae type b (Hib) Vaccine in Infants♦ 813

被引:0
|
作者
M M Blatter
K S Reisinger
D R Terwelp
F J DelBuono
B J Howe
机构
[1] Pittsburgh Ped Res,
[2] Ctr for Clin Res,undefined
[3] SmithKline Beecham (SB) Pharmaceuticals,undefined
关键词
D O I
10.1203/00006450-199804001-00834
中图分类号
学科分类号
摘要
引用
收藏
页码:141 / 141
相关论文
共 50 条
  • [31] Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine Implications for Disease Prevention in the United States
    Greenberg, David P.
    Doemland, Martha
    Bettinger, Julie A.
    Scheifele, David W.
    Halperin, Scott A.
    Waters, Valerie
    Kandola, Kami
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (06) : 521 - 528
  • [32] Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
    Klein, Nicola P.
    Abu-Elyazeed, Remon
    Cheuvart, Brigitte
    Janssens, Winnie
    Mesaros, Narcisa
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 809 - 821
  • [33] Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria-tetanus-acellular pertussis-Hib combination vaccines -: Reply
    Goldblatt, D
    Richmond, P
    Millard, E
    Miller, E
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06): : 2118 - 2118
  • [34] Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine
    Omenaca, Felix
    Garcia-Sicilia, Jose
    Garcia-Corbeira, Pilar
    Boceta, Reyes
    Torres, Victorio
    PEDIATRICS, 2007, 119 (01) : E179 - E185
  • [35] Immunogenicity of Diphtheria-Tetanus-Acellular Pertussis Vaccine Combined with Haemophilus influenzae Type b Polysaccharide-Tetanus Toxoid Conjugate Vaccine (DTaPH) in 2, 4, and 6 Month Old Infants ♦ 812
    Henry Bernstein
    Krista Garrison
    Evelyn Kurt-Jones
    Colin Marchant
    Pediatric Research, 1998, 43 (Suppl 4) : 141 - 141
  • [37] SAFETY AND IMMUNOGENICITY OF A COMBINED DIPHTHERIA, TETANUS, PERTUSSIS AND HAEMOPHILUS-INFLUENZAE TYPE-B VACCINE IN YOUNG INFANTS
    PARADISO, PR
    HOGERMAN, DA
    MADORE, DV
    KEYSERLING, H
    KING, J
    REISINGER, KS
    BLATTER, MM
    ROTHSTEIN, E
    BERNSTEIN, HH
    HACKELL, J
    PEDIATRICS, 1993, 92 (06) : 827 - 832
  • [38] Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type b combination vaccine in a placebo-controlled rotavirus vaccine study
    Phua, Kong Boo
    Quak, Seng Hock
    Lim, Fong Seng
    Goh, Paul
    Teoh, Yee Leong
    Datta, Sanjoy Kumar
    Han, Htay Htay
    Bock, Hans Ludwig
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (07) : 546 - 553
  • [39] Immunogenicity and safety of combined diphtheria-tetanus-whole cell pertussis-hepatitis B/haemophilus influenzae type b vaccine in Indian infants
    Bavdekar, S. B.
    Maiya, P. P.
    Rao, S. D. Subba
    Datta, S. K.
    Bock, H. L.
    INDIAN PEDIATRICS, 2007, 44 (07) : 505 - 510
  • [40] Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age
    Halperin, Scott A.
    Tapiero, Bruce
    Diaz-Mitoma, Francisco
    Law, Barbara J.
    Hoffenbach, Agnes
    Zappacosta, Pamela S.
    Radley, David
    McCarson, Barbara J.
    Martin, Jason C.
    Brackett, Laura E.
    Boslego, John W.
    Hesley, Teresa M.
    Bhuyan, Prakash K.
    Silber, Jeffrey L.
    VACCINE, 2009, 27 (19) : 2540 - 2547